MIRM Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 22.87%

Insider Buying (Last 12 Months): $74,700.35

Insider Selling (Last 12 Months): $7,304,987.14

Mirum Pharmaceuticals Insider Trading History Chart

Mirum Pharmaceuticals Share Price & Price History

^$45.99

▼ -0.09 (-0.20%)

As of 03/28/2025 05:00 PM ET

Days: 30 | 90 | 365

Mirum Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
3/17/2025	Christopher Peetz	CEO	Sell	27,279	$44.21	$1,206,004.59	138,641
3/17/2025	Jolanda Howe	SVP	Sell	57,606	$44.35	$2,554,826.10	4,841
3/17/2025	Peter Radovich	COO	Sell	7,879	$44.21	$348,330.59	18,672
3/4/2025	Patrick J. Heron	Director	Buy	1,335	$45.57	$60,835.95	163,643
2/3/2025	Christopher Peetz	CEO	Sell	9,102	$48.22	$438,898.44	115,920
2/3/2025	Jolanda Howe	SVP	Sell	1,064	$48.22	$51,306.08	4,232
2/3/2025	Peter Radovich	COO	Sell	2,627	$48.22	$126,673.94	26,961
1/24/2025	Christopher Peetz	CEO	Sell	6,837	$47.92	$327,629.04	125,022
1/24/2025	Jolanda Howe	SVP	Sell	902	$47.92	$43,223.84	3,524
1/24/2025	Peter Radovich	COO	Sell	3,177	$47.92	$152,241.84	29,588
1/17/2025	Joanne Quan	Insider	Sell	6,969	$45.86	$319,598.34	5,649
1/7/2025	Christopher Peetz	CEO	Sell	7,489	$42.82	$320,678.98	119,359
1/7/2025	Jolanda Howe	SVP	Sell	750	$42.82	$32,115.00	2,926
1/7/2025	Peter Radovich	COO	Sell	1,998	$42.82	$85,554.36	27,015
11/14/2024	Jolanda Howe	SVP	Sell	2,500	$47.10	$117,750.00	2,426
9/18/2024	Patrick J. Heron	Director	Buy	115	$37.40	$4,301.00	162,308
9/6/2024	Patrick J. Heron	Director	Buy	230	$41.58	$9,563.40	162,193
7/2/2024	Jolanda Howe	SVP	Sell	375	$34.00	$12,750.00	2,426
6/24/2024	Pamela Vig	Insider	Sell	30,559	$34.00	$1,039,006.00	27,406
6/5/2024	Saira Ramasastry	Director	Sell	5,000	$25.68	$128,400.00
3/27/2024	Eric Bjerkholt	CFO	Buy	2,000	$24.80	$49,600.00	14,000
3/25/2024	Peter Radovich	COO	Sell	4,303	$25.80	$111,017.40	29,013
3/18/2024	Eric Bjerkholt	CFO	Buy	2,000	$25.80	$51,600.00	12,000
2/2/2024	Jolanda Howe	SVP	Sell	735	$26.19	$19,249.65	1,759
1/8/2024	Christopher Peetz	CEO	Sell	5,209	$28.03	$146,008.27	110,125
1/8/2024	Jolanda Howe	SVP	Sell	528	$28.04	$14,805.12	722
1/8/2024	Lara Longpre	Insider	Sell	1,019	$28.04	$28,572.76	105,254
1/8/2024	Peter Radovich	COO	Sell	1,408	$28.03	$39,466.24	36,485
12/5/2023	Jolanda Howe	SVP	Sell	2,500	$32.40	$81,000.00
9/14/2023	Michael G. Grey	Director	Sell	14,216	$32.00	$454,912.00
9/11/2023	Eric Bjerkholt	CFO	Buy	10,000	$29.65	$296,500.00	10,000
9/11/2023	Patrick J. Heron	Director	Buy	4,687	$30.30	$142,016.10	152,678
8/31/2023	Patrick J. Heron	Director	Buy	147,991	$26.25	$3,884,763.75	147,991
8/25/2023	Jolanda Howe	SVP	Sell	3,459	$26.23	$90,729.57
7/3/2023	Christopher Peetz	CEO	Sell	5,498	$25.65	$141,023.70	115,334
7/3/2023	Jolanda Howe	SVP	Sell	915	$25.65	$23,469.75	3,459
7/3/2023	Lara Longpre	Insider	Sell	1,004	$25.65	$25,752.60	105,839
7/3/2023	Peter Radovich	COO	Sell	1,425	$25.65	$36,551.25	37,675
5/3/2023	Michael G. Grey	Director	Sell	14,608	$28.00	$409,024.00
11/14/2022	Niall O'donnell	Director	Sell	32,109	$19.60	$629,336.40	1,714,888
11/11/2022	Niall O'donnell	Director	Sell	174,121	$19.99	$3,480,678.79	1,746,997
6/6/2022	James E Flynn	Major Shareholder	Sell	38,478	$25.01	$962,334.78	1,540,190

See Full Table

SEC Filings (Institutional Ownership Changes) for Mirum Pharmaceuticals (NASDAQ:MIRM)

Institutional Buying and Selling by Quarter

Mirum Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
3/24/2025	Wellington Management Group LLP	118,201	$4.89M	0.0%	-3.4%	0.241%
3/5/2025	Phocas Financial Corp.	37,585	$1.55M	0.2%	-0.8%	0.077%
2/19/2025	GF Fund Management CO. LTD.	1,008	$42K	0.0%	N/A	0.002%
2/17/2025	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	73,888	$3.06M	0.0%	+16.4%	0.154%
2/17/2025	Voloridge Investment Management LLC	171,537	$7.09M	0.0%	-33.2%	0.357%
2/17/2025	Woodline Partners LP	404,404	$16.72M	0.1%	+22.2%	0.842%
2/17/2025	Squarepoint Ops LLC	21,682	$0.90M	0.0%	N/A	0.045%
2/17/2025	Two Sigma Advisers LP	174,400	$7.21M	0.0%	-15.1%	0.363%
2/17/2025	Two Sigma Investments LP	126,446	$5.23M	0.0%	-44.4%	0.263%
2/17/2025	Tang Capital Management LLC	1,237,107	$51.15M	3.4%	-3.9%	2.577%
2/17/2025	Tema Etfs LLC	41,968	$1.74M	0.7%	N/A	0.087%
2/17/2025	Sherbrooke Park Advisers LLC	6,355	$0.26M	0.1%	-6.3%	0.013%
2/17/2025	Silvercrest Asset Management Group LLC	136,700	$5.65M	0.0%	-1.0%	0.285%
2/17/2025	Rafferty Asset Management LLC	45,160	$1.87M	0.0%	-47.2%	0.094%
2/17/2025	Point72 Asia Singapore Pte. Ltd.	856	$35K	0.0%	N/A	0.002%
2/17/2025	ProShare Advisors LLC	13,457	$0.56M	0.0%	+31.5%	0.028%
2/17/2025	Prosight Management LP	451,127	$18.65M	5.2%	-3.2%	0.940%
2/17/2025	MPM Bioimpact LLC	589,579	$24.38M	3.5%	+19.7%	1.228%
2/17/2025	Patient Square Capital LP	64,900	$2.68M	1.0%	N/A	0.135%
2/17/2025	Man Group plc	6,989	$0.29M	0.0%	N/A	0.015%
2/17/2025	Nuveen Asset Management LLC	722,155	$29.86M	0.0%	+46.7%	1.504%
2/17/2025	OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC	25,059	$1.04M	0.1%	+51.5%	0.052%
2/17/2025	Millennium Management LLC	526,974	$21.79M	0.0%	+15.7%	1.098%
2/17/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	24,327	$1.01M	0.0%	-2.0%	0.051%
2/17/2025	Janus Henderson Group PLC	4,581,642	$189.48M	0.1%	+2.3%	9.543%
2/17/2025	Ensign Peak Advisors Inc	218,588	$9.04M	0.0%	-0.8%	0.455%
2/17/2025	D. E. Shaw & Co. Inc.	157,352	$6.51M	0.0%	N/A	0.328%
2/17/2025	Deutsche Bank AG	169,323	$7M	0.0%	+7.7%	0.353%
2/17/2025	Cubist Systematic Strategies LLC	83,969	$3.47M	0.0%	-15.0%	0.175%
2/17/2025	Boone Capital Management LLC	581,843	$24.06M	8.1%	+7.0%	1.212%
2/17/2025	Bosun Asset Management LLC	10,413	$0.43M	0.2%	+45.5%	0.022%
2/17/2025	Avidity Partners Management LP	666,200	$27.55M	2.7%	-8.9%	1.388%
2/17/2025	BVF Inc. IL	2,796,513	$115.64M	3.9%	-9.1%	5.825%
2/17/2025	Balyasny Asset Management L.P.	18,733	$0.78M	0.0%	N/A	0.039%
2/17/2025	Algert Global LLC	68,291	$2.82M	0.1%	N/A	0.142%
2/17/2025	AXA S.A.	425,646	$17.60M	0.1%	-0.1%	0.887%
2/14/2025	Comerica Bank	617	$26K	0.0%	-76.2%	0.001%
2/14/2025	Schonfeld Strategic Advisors LLC	17,200	$0.71M	0.0%	+2.9%	0.036%
2/14/2025	Northern Trust Corp	399,544	$16.52M	0.0%	+8.7%	0.832%
2/14/2025	The Manufacturers Life Insurance Company	21,625	$0.89M	0.0%	-2.2%	0.045%
2/14/2025	Tudor Investment Corp ET AL	23,966	$0.99M	0.0%	N/A	0.050%
2/14/2025	Aquatic Capital Management LLC	22,589	$0.93M	0.0%	+28.3%	0.047%
2/14/2025	Oxford Asset Management LLP	6,587	$0.27M	0.1%	N/A	0.014%
2/14/2025	Virtus ETF Advisers LLC	8,270	$0.34M	0.1%	-33.0%	0.017%
2/14/2025	Lord Abbett & CO. LLC	782,354	$32.35M	0.1%	+5.5%	1.630%
2/14/2025	Voya Investment Management LLC	27,608	$1.14M	0.0%	-3.2%	0.058%
2/14/2025	Penn Capital Management Company LLC	278,427	$11.51M	1.1%	-10.0%	0.580%
2/14/2025	Adage Capital Partners GP L.L.C.	150,000	$6.20M	0.0%	+87.5%	0.312%
2/14/2025	Syon Capital LLC	6,682	$0.28M	0.0%	N/A	0.014%
2/14/2025	Price T Rowe Associates Inc. MD	1,422,729	$58.83M	0.0%	+10.8%	2.963%
2/14/2025	Dark Forest Capital Management LP	7,460	$0.31M	0.0%	N/A	0.016%
2/14/2025	Harvest Investment Services LLC	5,707	$0.24M	0.1%	N/A	0.012%
2/14/2025	Hsbc Holdings PLC	6,504	$0.27M	0.0%	N/A	0.014%
2/14/2025	Rock Springs Capital Management LP	1,471,564	$60.85M	2.3%	-6.9%	3.065%
2/14/2025	Tower Research Capital LLC TRC	5,112	$0.21M	0.0%	+260.5%	0.011%
2/14/2025	MetLife Investment Management LLC	24,085	$1M	0.0%	+6.0%	0.050%
2/14/2025	Nan Fung Group Holdings Ltd	125,330	$5.18M	4.4%	+18.1%	0.261%
2/14/2025	First Trust Advisors LP	134,181	$5.55M	0.0%	-8.4%	0.279%
2/14/2025	Alpha DNA Investment Management LLC	10,663	$0.44M	0.2%	N/A	0.022%
2/13/2025	Canada Pension Plan Investment Board	41,800	$1.73M	0.0%	N/A	0.087%
2/13/2025	Marshall Wace LLP	175,913	$7.27M	0.0%	+641.6%	0.366%
2/13/2025	EAM Investors LLC	72,956	$3.02M	0.4%	-23.5%	0.152%
2/13/2025	Affinity Asset Advisors LLC	70,742	$2.93M	0.4%	-5.7%	0.147%
2/13/2025	Jump Financial LLC	37,634	$1.56M	0.0%	-19.5%	0.078%
2/13/2025	XTX Topco Ltd	14,861	$0.62M	0.1%	N/A	0.031%
2/13/2025	Barclays PLC	251,964	$10.42M	0.0%	+2.5%	0.525%
2/13/2025	Summit Investment Advisors Inc.	4,155	$0.17M	0.2%	+8.1%	0.009%
2/13/2025	Capital Fund Management S.A.	27,322	$1.13M	0.0%	N/A	0.057%
2/13/2025	Renaissance Technologies LLC	101,248	$4.19M	0.0%	+67.5%	0.211%
2/13/2025	Legal & General Group Plc	40,820	$1.69M	0.0%	+3.5%	0.085%
2/13/2025	Invesco Ltd.	299,279	$12.38M	0.0%	+5.2%	0.623%
2/13/2025	Federated Hermes Inc.	3,641	$0.15M	0.0%	-9.0%	0.008%
2/13/2025	Russell Investments Group Ltd.	25,960	$1.07M	0.0%	+8.1%	0.054%
2/13/2025	Rhenman & Partners Asset Management AB	73,755	$3.05M	0.3%	-29.8%	0.154%
2/12/2025	ExodusPoint Capital Management LP	22,153	$0.92M	0.0%	N/A	0.046%
2/12/2025	Geode Capital Management LLC	943,344	$39.02M	0.0%	+0.8%	1.965%
2/12/2025	Wellington Management Group LLP	118,201	$4.89M	0.0%	-3.4%	0.246%
2/12/2025	Clearbridge Investments LLC	907,317	$37.52M	0.0%	+2.0%	1.890%
2/12/2025	Pictet Asset Management Holding SA	860,096	$35.57M	0.0%	-4.0%	1.791%
2/12/2025	Loomis Sayles & Co. L P	578,024	$23.90M	2.6%	+15.8%	1.204%
2/12/2025	NEOS Investment Management LLC	17,693	$0.73M	0.0%	-60.4%	0.037%
2/11/2025	Corebridge Financial Inc.	19,746	$0.82M	0.0%	-5.9%	0.041%
2/11/2025	Congress Wealth Management LLC DE	10,000	$0.41M	0.0%	N/A	0.021%
2/11/2025	Vanguard Group Inc.	2,424,734	$100.26M	0.0%	-2.9%	5.050%
2/11/2025	KLP Kapitalforvaltning AS	6,700	$0.28M	0.0%	N/A	0.014%
2/11/2025	Teacher Retirement System of Texas	10,613	$0.44M	0.0%	+19.7%	0.022%
2/10/2025	Swiss National Bank	70,300	$2.91M	0.0%	+1.9%	0.146%
2/10/2025	Connor Clark & Lunn Investment Management Ltd.	176,960	$7.32M	0.0%	+162.6%	0.369%
2/7/2025	AlphaQuest LLC	1,829	$76K	0.0%	+969.6%	0.004%
2/7/2025	Candriam S.C.A.	429,731	$17.77M	0.1%	-15.5%	0.895%
2/6/2025	Raymond James Financial Inc.	256,612	$10.61M	0.0%	N/A	0.534%
2/6/2025	Aigen Investment Management LP	7,742	$0.32M	0.1%	N/A	0.016%
2/6/2025	Charles Schwab Investment Management Inc.	332,639	$13.76M	0.0%	+1.4%	0.693%
2/6/2025	Jones Financial Companies Lllp	714	$30K	0.0%	+100.0%	0.001%
2/5/2025	Phocas Financial Corp.	5,699	$0.24M	0.2%	-85.0%	0.012%
2/4/2025	Bank of New York Mellon Corp	124,328	$5.14M	0.0%	+8.4%	0.259%
2/4/2025	HealthInvest Partners AB	116,692	$4.81M	2.2%	-15.6%	0.243%
1/31/2025	Rice Hall James & Associates LLC	238,999	$9.88M	0.5%	-1.5%	0.498%
1/30/2025	Rhumbline Advisers	53,113	$2.20M	0.0%	+2.4%	0.111%
1/29/2025	Values First Advisors Inc.	19,840	$0.82M	0.5%	-16.4%	0.041%

Data available starting January 2016

See Full Table

Mirum Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of novel therapies for debilitating rare and orphan diseases. Its lead product candidate is LIVMARLI (maralixibat), an orally administered and minimally absorbed ileal bile acid transporter (IBAT) inhibitor that is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome in the United States and internationally. The company is also involved in the commercialization of Cholbam, a cholic acid capsule, which is approved as treatment for pediatric and adult patients with bile acid synthesis disorders due to single enzyme defects and for adjunctive treatment of patients with peroxisomal disorders, including peroxisome biogenesis disorder-Zellweger spectrum disorder and Smith-Lemli-Opitz syndrome; and Chenodal, a tablet, which is approved for the treatment of radiolucent stones in the gallbladder, and under Phase 3 development for the treatment cerebrotendinous xanthomatosis. In addition, it develops Volixibat, an oral and minimally absorbed agent designed to inhibit IBAT, currently under Phase 2b clinical trial for the treatment of adult patients with cholestatic liver diseases. The company was incorporated in 2018 and is headquartered in Foster City, California.

Today's Range

Now: $45.99

$45.79

$46.52

50 Day Range

MA: $48.01

$43.01

$53.16

52 Week Range

Now: $45.99

$23.14

$54.23

Volume

155,893 shs

Average Volume

520,782 shs

Market Capitalization

$2.25 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.04

Who are the company insiders with the largest holdings of Mirum Pharmaceuticals?: Mirum Pharmaceuticals' top insider investors include:
Patrick J Heron (Director)
Christopher Peetz (CEO)
Lara Longpre (Insider)
Peter Radovich (COO)
Pamela Vig (Insider)
Eric Bjerkholt (CFO)
Joanne Quan (Insider)
Jolanda Howe (SVP)
Michael G Grey (Director)
Saira Ramasastry (Director)
Learn More about top insider investors at Mirum Pharmaceuticals.
Who are the major institutional investors of Mirum Pharmaceuticals?: Mirum Pharmaceuticals' top institutional investors include:
Janus Henderson Group PLC — 9.54%
BVF Inc. IL — 5.82%
Vanguard Group Inc. — 5.05%
Rock Springs Capital Management LP — 3.07%
Price T Rowe Associates Inc. MD — 2.96%
Tang Capital Management LLC — 2.58%
Learn More about top institutional investors of Mirum Pharmaceuticals stock.
Which institutional investors are selling Mirum Pharmaceuticals stock?: During the last quarter, MIRM stock was sold by these institutional investors:
BVF Inc. IL
Rock Springs Capital Management LP
Two Sigma Investments LP
Voloridge Investment Management LLC
Candriam S.C.A.
Vanguard Group Inc.
Avidity Partners Management LP
Tang Capital Management LLC
Within the last year, company insiders that have sold Mirum Pharmaceuticals company stock include:
Patrick J Heron (Director)
Christopher Peetz (CEO)
Lara Longpre (Insider)
Peter Radovich (COO)
Pamela Vig (Insider)
Eric Bjerkholt (CFO)
Learn More investors selling Mirum Pharmaceuticals stock.
Which institutional investors are buying Mirum Pharmaceuticals stock?: In the last quarter, MIRM stock was bought by institutional investors including:
Raymond James Financial Inc.
Nuveen Asset Management LLC
D. E. Shaw & Co. Inc.
Marshall Wace LLP
Price T Rowe Associates Inc. MD
Connor Clark & Lunn Investment Management Ltd.
Janus Henderson Group PLC
MPM Bioimpact LLC
Within the last year, these company insiders have bought Mirum Pharmaceuticals stock:
Patrick J Heron (Director)
Christopher Peetz (CEO)
Learn More investors buying Mirum Pharmaceuticals stock.